Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 7Fatigue 3Pain 2Vomiting 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Multiple Myeloma 1Mucositis 1Lung Neoplasms 1Leukemia 1Ileus 1Hot Flashes 1Hematologic Neoplasms 1Graft vs Host Disease 1Female Breast Cancer 1Depression 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms, Male 1

Interventions

Dexamethasone 112Bortezomib 61Lenalidomide 49Cyclophosphamide 49Calcium Dobesilate 43pomalidomide 32Melphalan 31fludarabine 25Filgrastim 25carfilzomib 22fludarabine phosphate 21daratumumab 20Granulocyte Colony-Stimulating Factor 16Whole-Body Irradiation 15Antilymphocyte Serum 15dexamethasone acetate 14Mycophenolic Acid 14Thalidomide 13Tacrolimus 13Cyclosporine 13Busulfan 13Peripheral Blood Stem Cell Transplantation 12ixazomib 11dexamethasone 21-phosphate 10auricularum 10pembrolizumab 9Radiotherapy 9Etoposide 9belantamab mafodotin 8Rituximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Multiple Myeloma × Acupuncture Therapy × Clear all
NCT04770402 2025-01-27

Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients

Wake Forest University Health Sciences

Phase NA Terminated
12 enrolled 18 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡